Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.
暂无分享,去创建一个
E. P. Dellinger | Soumitra R. Eachempati | J. Bartlett | E. Baron | A. Nathens | E. Goldstein | J. Solomkin | A. May | J. Mazuski | R. Sawyer | P. O’neill | A. Chow | S. Gorbach | J. Bradley | K. Rodvold | M. Hilfiker | P. O’Neill | E. Dellinger
[1] H. Dupont,et al. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. , 2009, The Journal of antimicrobial chemotherapy.
[2] H. Evans,et al. Choosing antibiotics for intra-abdominal infections: what do we mean by "high risk"? , 2009, Surgical infections.
[3] J. Mazuski. Vancomycin-resistant enterococcus: risk factors, surveillance, infections, and treatment. , 2008, Surgical infections.
[4] S. Strasberg. Clinical practice. Acute calculous cholecystitis. , 2008, The New England journal of medicine.
[5] S. S. St. Peter,et al. Single daily dosing ceftriaxone and metronidazole vs standard triple antibiotic regimen for perforated appendicitis in children: a prospective randomized trial. , 2008, Journal of pediatric surgery.
[6] H. Hof,et al. Developments in the epidemiolgy of invasive fungal infections – implications for the empiric and targeted antifungal therapy , 2008, Mycoses.
[7] M. Henry,et al. Neonatal necrotizing enterocolitis. , 2008, Seminars in pediatric surgery.
[8] H. Ford,et al. Evidence vs experience in the surgical management of necrotizing enterocolitis and focal intestinal perforation , 2008, Journal of Perinatology.
[9] C. Nankervis,et al. The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis. , 2008, Seminars in perinatology.
[10] J. D. De Waele,et al. Blood stream infections of abdominal origin in the intensive care unit: characteristics and determinants of death. , 2008, Surgical infections.
[11] M. Levy,et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.
[12] T. Calandra,et al. Bench-to-bedside review: Candida infections in the intensive care unit , 2008, Critical care.
[13] J. Bartlett,et al. Clinical recognition and diagnosis of Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] Rolf Rossaint,et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.
[15] M. Pfaller,et al. In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance , 2007, Journal of Clinical Microbiology.
[16] R. Andersson,et al. Nonsurgical Treatment of Appendiceal Abscess or Phlegmon: A Systematic Review and Meta-analysis , 2007, Annals of surgery.
[17] Atlanta,et al. Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States , 2007 .
[18] R. Betts,et al. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] E. Buskens,et al. Randomized Controlled Trials of Antibiotic Prophylaxis in Severe Acute Pancreatitis: Relationship between Methodological Quality and Outcome , 2007, Pancreatology.
[20] G. Drusano,et al. Back to the future: using aminoglycosides again and how to dose them optimally. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] D. Gouma,et al. Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. , 2007, JAMA.
[22] K. Waites,et al. USA300 Genotype Community-Associated Methicillin-Resistant Staphylococcus aureus as a Cause of Surgical Site Infections , 2007, Journal of Clinical Microbiology.
[23] D. T. Bearden,et al. Antimicrobial Dosing Considerations in Obese Adult Patients , 2007, Pharmacotherapy.
[24] J. Byerley,et al. Does this child have appendicitis? , 2007, JAMA.
[25] Jessina C. McGregor,et al. Predictors of 30-Day Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: Impact of Delayed Appropriate Antibiotic Selection , 2007, Antimicrobial Agents and Chemotherapy.
[26] R. Betts,et al. Anidulafungin versus fluconazole for invasive candidiasis. , 2007, The New England journal of medicine.
[27] R. Bachur,et al. Evaluating appendicitis scoring systems using a prospective pediatric cohort. , 2007, Annals of emergency medicine.
[28] Michelle M. Garrison,et al. Aminoglycoside-Based Triple-Antibiotic Therapy Versus Monotherapy for Children With Ruptured Appendicitis , 2007, Pediatrics.
[29] J. Tomassini,et al. Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults. , 2007, Surgical infections.
[30] J. Gerstle,et al. Necrotizing enterocolitis: review of state-of-the-art imaging findings with pathologic correlation. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.
[31] N. V. Jacobus,et al. National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004 , 2007, Antimicrobial Agents and Chemotherapy.
[32] G. Drusano,et al. Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] Wajeeh Salah,et al. 'Streptococcus milleri' aortic valve endocarditis and hepatic abscess. , 2007, Journal of medical microbiology.
[34] D. Gouma,et al. Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis , 2007, Journal of hepato-biliary-pancreatic surgery.
[35] Masahiro Yoshida,et al. Results of the Tokyo Consensus Meeting Tokyo Guidelines , 2007, Journal of hepato-biliary-pancreatic surgery.
[36] D. Gouma,et al. Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines , 2007, Journal of hepato-biliary-pancreatic surgery.
[37] L. Corfield. Interval Appendicectomy After Appendiceal Mass or Abscess in Adults: What is “Best Practice”? , 2006, Surgery Today.
[38] H. Evans,et al. Can we define the ideal duration of antibiotic therapy? , 2006, Surgical infections.
[39] James D Dziura,et al. Is It Safe to Delay Appendectomy in Adults With Acute Appendicitis? , 2006, Annals of surgery.
[40] M. Pfaller,et al. Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Voriconazole among 13,338 Clinical Isolates of Candida spp. Tested by Clinical and Laboratory Standards Institute-Recommended Broth Microdilution Methods , 2006, Journal of Clinical Microbiology.
[41] S. Emil,et al. What are the True Advantages of a Pediatric Appendicitis Clinical Pathway? , 2006, The American surgeon.
[42] P. Babyn,et al. US or CT for Diagnosis of Appendicitis in Children and Adults? A Meta-Analysis. , 2006, Radiology.
[43] D. Bratzler,et al. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[44] M. White. Components and mechanisms of thermal hyperpnea. , 2006, Journal of applied physiology.
[45] G. Drusano,et al. Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazole. , 2006, Diagnostic microbiology and infectious disease.
[46] M. Malangoni,et al. Randomized Controlled Trial of Moxifloxacin Compared With Piperacillin–Tazobactam and Amoxicillin–Clavulanate for the Treatment of Complicated Intra-abdominal Infections , 2006, Annals of surgery.
[47] Wei-Jen Lin,et al. Bacteriology and antibiotic susceptibility of community-acquired intra-abdominal infection in children. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[48] K. Wood,et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.
[49] S. S. St. Peter,et al. A simple and more cost-effective antibiotic regimen for perforated appendicitis. , 2006, Journal of pediatric surgery.
[50] J. Styrud,et al. Appendectomy versus Antibiotic Treatment in Acute Appendicitis. A Prospective Multicenter Randomized Controlled Trial , 2006, World Journal of Surgery.
[51] M. Franklin,et al. Morbidity of laparoscopic surgery for complicated appendicitis: an international study , 2006, Surgical Endoscopy And Other Interventional Techniques.
[52] C. Hennequin,et al. Candida as a risk factor for mortality in peritonitis* , 2006, Critical care medicine.
[53] E. Goldstein,et al. In Vitro Activity of Moxifloxacin against 923 Anaerobes Isolated from Human Intra-Abdominal Infections , 2006, Antimicrobial Agents and Chemotherapy.
[54] S. Emil,et al. Emergent vs urgent appendectomy in children: a study of outcomes. , 2005, Journal of pediatric surgery.
[55] E. Loh,et al. A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744] , 2005, BMC infectious diseases.
[56] R. Herings,et al. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. , 2005, British journal of clinical pharmacology.
[57] U. Schaad. Fluoroquinolone antibiotics in infants and children. , 2005, Infectious disease clinics of North America.
[58] A. Kaminski,et al. Routine interval appendectomy is not justified after initial nonoperative treatment of acute appendicitis. , 2005, Archives of surgery.
[59] N. Karabulut,et al. Percutaneous Drainage of 300 Intraperitoneal Abscesses with Long-Term Follow-Up , 2005, CardioVascular and Interventional Radiology.
[60] C. Sirlin,et al. CT evaluation of appendicitis and its complications: imaging techniques and key diagnostic findings. , 2005, AJR. American journal of roentgenology.
[61] F. Baquero,et al. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). , 2005, The Journal of antimicrobial chemotherapy.
[62] R. Halvorsen,et al. Helical CT evaluation of acute right lower quadrant pain: part I, common mimics of appendicitis. , 2005, AJR. American journal of roentgenology.
[63] D. Bratzler,et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. , 2005, American journal of surgery.
[64] W. Weiss,et al. Current concepts of percutaneous abscess drainage in postoperative retention , 2005, Journal of Gastrointestinal Surgery.
[65] J. Marshall,et al. Source control in the management of severe sepsis and septic shock: An evidence-based review , 2004, Critical care medicine.
[66] C. Edmiston,et al. Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels? , 2004, Surgery.
[67] R. Rogers,et al. Tetracycline and other tetracycline‐derivative staining of the teeth and oral cavity , 2004, International journal of dermatology.
[68] S. Sen,et al. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery , 2004, European Journal of Clinical Microbiology and Infectious Diseases.
[69] D. Sahani,et al. The inaccessible or undrainable abscess: how to drain it. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.
[70] George L. Drusano,et al. Antimicrobial pharmacodynamics: critical interactions of 'bug and drug' , 2004, Nature Reviews Microbiology.
[71] D. Smink,et al. Diagnosis of acute appendicitis in children using a clinical practice guideline. , 2004, Journal of pediatric surgery.
[72] Claude D Martin,et al. Clinical and Therapeutic Features of Nonpostoperative Nosocomial Intra-abdominal Infections , 2004 .
[73] J. Sobel,et al. Guidelines for treatment of candidiasis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[74] M. Hogan. Appendiceal abscess drainage. , 2003, Techniques in vascular and interventional radiology.
[75] E. P. Dellinger,et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[76] M. Bonten,et al. Epidemic and Nonepidemic Multidrug-Resistant Enterococcus faecium , 2003, Emerging infectious diseases.
[77] D. Snydman,et al. Emergence of fluoroquinolone resistance among Bacteroides species. , 2003, The Journal of antimicrobial chemotherapy.
[78] S. Mulier,et al. Factors Affecting Mortality in Generalized Postoperative Peritonitis: Multivariate Analysis in 96 Patients , 2003, World Journal of Surgery.
[79] N. Christou,et al. Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections , 2003 .
[80] E. Paulson,et al. Clinical practice. Suspected appendicitis. , 2003, The New England journal of medicine.
[81] J. Perfect,et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. , 2002, The New England journal of medicine.
[82] K. Aldridge,et al. In Vitro Susceptibilities of the Bacteroides fragilis Group Species: Change in Isolation Rates Significantly Affects Overall Susceptibility Data , 2002, Journal of Clinical Microbiology.
[83] D. Snydman,et al. In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms , 2002, Antimicrobial Agents and Chemotherapy.
[84] A. Nathens,et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. , 2002, Surgical infections.
[85] HUMAN METAPNEUMOVIRUS AS A CAUSE OF COMMUNITY-ACQUIRED RESPIRATORY ILLNESS , 2002 .
[86] K. Holmes,et al. Prospective evaluation of nonsurgical versus surgical management of appendiceal mass. , 2002, Journal of pediatric surgery.
[87] J. Truebenbach,et al. CT-guided percutaneous drainage of intra-abdominal abscesses: APACHE III score stratification of 1-year results , 2002, European Radiology.
[88] J. Coast,et al. Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness , 2002, Journal of health services research & policy.
[89] M. Girvent,et al. Postoperative enterococcal infection after treatment of complicated intra‐abdominal sepsis , 2002, The British journal of surgery.
[90] R. Weinstein,et al. Vancomycin-resistant enterococci: why are they here, and where do they come from? , 2001, The Lancet. Infectious diseases.
[91] R. Azizkhan,et al. Results of a pilot trial comparing prolonged intravenous antibiotics with sequential intravenous/oral antibiotics for children with perforated appendicitis. , 2001, Archives of surgery.
[92] C E Nord,et al. Effect of antimicrobial agents on the ecological balance of human microflora. , 2001, The Lancet. Infectious diseases.
[93] H. Maltezou,et al. Piperacillin/Tazobactam Versus Cefotaxime Plus Metronidazole for Treatment of Children with Intra-Abdominal Infections Requiring Surgery , 2001, European Journal of Clinical Microbiology and Infectious Diseases.
[94] F. V. van Tiel,et al. Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients. , 2001, JAMA.
[95] S. Wilson,et al. Results of a Clinical Trial of Clinafloxacin Versus Imipenem/Cilastatin for Intraabdominal Infections , 2001, Annals of surgery.
[96] O. Gómez-Marín,et al. Comparison of two antibiotic regimens in the treatment of perforated appendicitis in pediatric patients. , 2000, International journal of clinical pharmacology and therapeutics.
[97] P Wright,et al. Changing pattern of organ dysfunction in early human sepsis is related to mortality , 2000, Critical care medicine.
[98] H. Oh,et al. Ecological Disturbances in Intestinal Microflora Caused by Clinafloxacin, an Extended-Spectrum Quinolone , 2000, Infection.
[99] I. Brook,et al. Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. , 2000, Journal of medical microbiology.
[100] P. Lipsett,et al. Comparison of Intravenous/Oral Ciprofloxacin Plus Metronidazole Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections , 2000, Annals of surgery.
[101] G Sherman,et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.
[102] D. Snydman,et al. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[103] E. Fishman,et al. Targeted helical CT of the acute abdomen: appendicitis, diverticulitis, and small bowel obstruction. , 2000, Seminars in ultrasound, CT, and MR.
[104] J. Lucet,et al. Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: relation to nasal colonization. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[105] Z. Mariak,et al. Direct cooling of the human brain by heat loss from the upper respiratory tract. , 1999, Journal of applied physiology.
[106] D. Snydman,et al. Multicenter Study of In Vitro Susceptibility of theBacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996 , 1999, Antimicrobial Agents and Chemotherapy.
[107] H. Forssell,et al. Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections. , 1999, The European journal of surgery = Acta chirurgica.
[108] P. Francioli,et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. , 1999, Critical care medicine.
[109] M. Silen,et al. The impact of intraoperative culture on treatment and outcome in children with perforated appendicitis. , 1999, Journal of pediatric surgery.
[110] K. Lamp,et al. Pharmacokinetics and Pharmacodynamics of the Nitroimidazole Antimicrobials , 1999, Clinical pharmacokinetics.
[111] G Sherman,et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. , 1999, Chest.
[112] R. Bennion,et al. Ticarcillin/Clavulanate versus Imipenem/Cilistatin for the Treatment of Infections Associated with Gangrenous and Perforated Appendicitis , 1999, The American surgeon.
[113] C. Ohmann,et al. Risk factors associated with intraabdominal infections: a prospective multicenter study , 1999, Langenbeck's Archives of Surgery.
[114] P. Bourbeau,et al. Use of the BacT/Alert Blood Culture System for Culture of Sterile Body Fluids Other than Blood , 1998, Journal of Clinical Microbiology.
[115] C. Ohmann. Prognostic scores and design of clinical studies , 1998, Infection.
[116] P. Barie,et al. A Randomized, Double-blind Clinical Trial Comparing Cefepime Plus Metronidazole With Imipenem-Cilastatin in the Treatment of Complicated Intra-abdominal Infections , 1997 .
[117] S. Dougherty,et al. Antimicrobial culture and susceptibility testing has little value for routine management of secondary bacterial peritonitis. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[118] J. Griffith,et al. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections , 1996, European Journal of Clinical Microbiology and Infectious Diseases.
[119] D. Snydman,et al. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[120] J. Carpenter,et al. Does this patient have appendicitis? , 1996, JAMA.
[121] P. Montravers,et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[122] A. Bufalari,et al. Postoperative intraabdominal abscesses: percutaneous versus surgical treatment. , 1996, Acta chirurgica Belgica.
[123] T. Hau,et al. Predictors of outcome in patients with postoperative intra-abdominal infection. , 1996, The European journal of surgery = Acta chirurgica.
[124] J. Bohnen,et al. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group. , 1996, Annals of surgery.
[125] T. Koperna,et al. Prognosis and treatment of peritonitis. Do we need new scoring systems? , 1996, Archives of surgery.
[126] J. Bohnen,et al. Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial. , 1995, Surgery.
[127] F Doyon,et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.
[128] S. Lemeshow,et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study , 1993 .
[129] P. Barie,et al. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group. , 1993, The American surgeon.
[130] C. Ohmann,et al. Prospective evaluation of prognostic scoring systems in peritonitis. Peritonitis Study Group. , 1993, The European journal of surgery = Acta chirurgica.
[131] Jeffrey W. Smith,et al. Efficacy of a β-Lactamase Inhibitor Combination for Serious Intra-abdominal Infections , 1993 .
[132] P. Barie,et al. Surgical Infection Society intra-abdominal infection study. Prospective evaluation of management techniques and outcome. , 1993, Archives of surgery.
[133] Levison Ma. Percutaneous versus open operative drainage of intra-abdominal abscesses. , 1992, Infectious disease clinics of North America.
[134] D. Snydman,et al. Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis , 1992, Antimicrobial Agents and Chemotherapy.
[135] W. Knaus,et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. , 1991, Chest.
[136] R. Milne,et al. Antibiotic treatment for surgical peritonitis. , 1991, Annals of surgery.
[137] L M Napolitano,et al. Prospective comparison of clinical judgment and APACHE II score in predicting the outcome in critically ill surgical patients. , 1991, The Journal of trauma.
[138] L. Navér,et al. Ceftriaxone/metronidazole is more effective than ampicillin/netilmicin/metronidazole in the treatment of bacterial peritonitis. , 1991, The European journal of surgery = Acta chirurgica.
[139] J. Solomkin,et al. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. , 1990, Annals of surgery.
[140] W. Knaus,et al. Proposed definitions for diagnosis, severity scoring, stratification, and outcome for trials on intraabdominal infection , 1990, World Journal of Surgery.
[141] P. Francioli,et al. CLINICAL SIGNIFICANCE OF CANDIDA ISOLATED FROM PERITONEUM IN SURGICAL PATIENTS , 1989, The Lancet.
[142] N. Jacobus,et al. Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation , 1988, Antimicrobial Agents and Chemotherapy.
[143] R. Jeffrey,et al. Periappendiceal inflammatory masses: CT-directed management and clinical outcome in 70 patients. , 1988, Radiology.
[144] R. Simmons,et al. Status of percutaneous catheter drainage of abscesses. , 1988, The Surgical clinics of North America.
[145] D. Snydman,et al. Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates. , 1987, Diagnostic microbiology and infectious disease.
[146] P. Bagi,et al. Nonoperative management of the ultrasonically evaluated appendiceal mass. , 1987, Surgery.
[147] A Alvarado,et al. A practical score for the early diagnosis of acute appendicitis. , 1986, Annals of emergency medicine.
[148] P. Colletti,et al. Real-time sonography in suspected acute cholecystitis. Prospective evaluation of primary and secondary signs. , 1985, Radiology.
[149] A. Robbins,et al. Expanded criteria for percutaneous abscess drainage. , 1985, Archives of surgery.
[150] H. Jensen,et al. Appendix mass: conservative management without interval appendectomy. , 1984, American journal of surgery.
[151] B. Ljungberg,et al. Metronidazole: pharmacokinetic observations in severely ill patients. , 1984, The Journal of antimicrobial chemotherapy.
[152] P. Mueller,et al. Percutaneous drainage of 250 abdominal abscesses and fluid collections. Part I: Results, failures, and complications. , 1984, Radiology.
[153] T. Berne,et al. Antibiotic management of surgically treated gangrenous or perforated appendicitis. Comparison of gentamicin and clindamycin versus cefamandole versus cefoperazone. , 1982, American journal of surgery.
[154] E. Dellinger,et al. Implications of Leukocytosis and Fever at Conclusion of Antibiotic Therapy for Intra‐abdominal Sepsis , 1982, Annals of surgery.
[155] D. Birkett,et al. Percutaneous catheter drainage of abdominal abscesses. , 1981, The New England journal of medicine.
[156] R. L. Simmons,et al. The role of Candida in intraperitoneal infections. , 1980, Surgery.
[157] D. Birkett,et al. Computed tomography in the diagnosis and management of abdominal abscesses , 1978, Gastrointestinal Radiology.
[158] B. A. Barnes,et al. Treatment of appendicitis at the Massachusetts General Hospital (1937-1959). , 1962, JAMA.
[159] M. Bizzarro,et al. Necrotizing Enterocolitis in Newborns , 2012, Drugs.
[160] S. Blot,et al. Critical Issues in the Clinical Management of Complicated Intra-Abdominal Infections , 2012, Drugs.
[161] J. Roberts,et al. Antibacterial Dosing in Intensive Care , 2006, Clinical pharmacokinetics.
[162] M. Bonten,et al. Vancomycin-resistant enterococci: consequences for therapy and infection control. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[163] P. Viale,et al. Antimicrobial Therapy in Critically Ill Patients , 2005, Clinical pharmacokinetics.
[164] H. Ford,et al. Monotherapy versus multi-drug therapy for the treatment of perforated appendicitis in children. , 2003, Surgical infections.
[165] A. Nathens,et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. , 2002, Surgical infections.
[166] A. Nathens,et al. Aminoglycosides for intra-abdominal infection: equal to the challenge? , 2002, Surgical infections.
[167] E. Wald,et al. Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis. , 2001, The Pediatric infectious disease journal.
[168] T. Koperna,et al. Relaparotomy in Peritonitis: Prognosis and Treatment of Patients with Persisting Intraabdominal Infection , 2000, World Journal of Surgery.
[169] A. Viste,et al. A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections. , 1996, Scandinavian journal of infectious diseases.
[170] J. Meakins,et al. Surgical infection stratification system for intra-abdominal infection. Multicenter trial. , 1985, Archives of surgery.
[171] P. Sones. Percutaneous drainage of abdominal abscesses. , 1984, AJR. American journal of roentgenology.
[172] D. Gerding,et al. Infection Control and Hospital Epidemiology Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals Shea Position Paper Infection Co , 2022 .